Development of chemical and rapid identification of the target molecules and ligand binding sites with high resolution

开发高分辨率的化学和快速鉴定靶分子和配体结合位点的方法

基本信息

  • 批准号:
    12470483
  • 负责人:
  • 金额:
    $ 8.64万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2002
  • 项目状态:
    已结题

项目摘要

In this project we aim to develop a method for rapid identification of the target molecules and ligand binding sites with high resolution in the recourse of immunoaffinity purification by anti-ligand antibodies, followed by moderen mass spectrometry. We planed to develop the method for identifying the binding site(s) of glutathione conjugate in cMOAT, an ATP-driven drug trasporter. During the passed 3 years, we obtained the results as follows. (1) We raised a antibody against hapten having analogous structure to photolabeling reagent of TOY-SG, a glutathione derivative. The antibody has a high titer to able to recognize hapten at sub-picomole level. (2) cMOAT protein that was photolabeled by TOY-SG was prepared and purified. We established the conditions of Lys-C digestion, which gave the photolabeled fragments of 3-4 kDa, proper size for MS nalysis. The photolabeled fragments were subjected to immunoaffinify purification using the anti-hapten antibody, but the yield was as low as 〜5%, which was not applicable for further MS analysis. (3) We fractionated the Lys-C fragments by HPLC as an alternative method and the fractions containing photolabeled fragments was analyzed by MALDI-TOF MS. We revealed two new photolabeled sites that located near nucleotide binding sites. The sites had not identified by any other methods such as site-directed mutagenesis. (4) Efforts to raise anti-hapten antibodies with much higher titer are still required.
在这个项目中,我们旨在开发I方法,以快速识别抗球形抗体的降压位置,并具有高分辨率,然后使用Moderen质谱法。谷胱甘肽在CMOAT中的结合物,ATP-drug trasporter是一种抗体,它具有与Toy-SG的相似结构,该抗体是谷胱甘肽衍生物的抗体。 SG制备并纯化。低至〜5%,这不适用于进一步的MS分析(3)我们分馏了Lys-C碎片方法,并通过MALDI-TOF MS分析了分级的光片片段。结合坐着。

项目成果

期刊论文数量(60)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A.Kuniyasu, et al.: "CD36-mediated endocytic uptake of AGE in mouse 3T3-L1 and human subcutaneous adipocytes"FEBS Lett.. 537. 85-90 (2003)
A.Kuniyasu 等人:“CD36 介导的小鼠 3T3-L1 和人皮下脂肪细胞中 AGE 的内吞摄取”FEBS Lett.. 537. 85-90 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Kawahara, et al.: "Induction of CHOP and apoptosis by nitric oxide in p53-deficient microglial cells"FEBS Lett.. 506(2). 135-139 (2001)
K.Kawahara 等人:“p53 缺陷型小胶质细胞中一氧化氮诱导 CHOP 和细胞凋亡”FEBS Lett.. 506(2)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Kawahara, et al.: "Efficient identification of photolabeled amino acids by mmuno-purification and mass spectrometry"Biochem. J.. 363(2). 223-232 (2002)
K.Kawahara 等人:“通过免疫纯化和质谱法有效鉴定光标记氨基酸”Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.Ohgami et al.: "Glibenclamide acts as an inhibitor of acyl-CoA : cholesterol acyltransferase enzyme"Biochem.Biophys.Res.Commun.. 277. 417-422 (2000)
N.Ohgami 等人:“格列本脲作为酰基辅酶 A 的抑制剂:胆固醇酰基转移酶”Biochem.Biophys.Res.Commun. 277. 417-422 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A.Kuniyasu, et al.: "Adipocytes recognize and degrade oxidized LDL through CD36"Biochem. Biophys. Res. Commun.. 295(2). 319-323 (2002)
A.Kuniyasu 等人:“脂肪细胞通过 CD36 识别并降解氧化的 LDL”Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKAYAMA Hitoshi其他文献

NAKAYAMA Hitoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKAYAMA Hitoshi', 18)}}的其他基金

The glycosphingolipid-mediated recognition of mycobacteria by human phagocytes
鞘糖脂介导的人类吞噬细胞对分枝杆菌的识别
  • 批准号:
    25860831
  • 财政年份:
    2013
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Semantic and Pragmatic Studies in the Relationship Between the English Relative Clause and Its Main Clause
英语关系从句与主句关系的语义和语用研究
  • 批准号:
    24520548
  • 财政年份:
    2012
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pragmatic Studies in Exceptional English Usage : Interpretation of Subordinate Clauses
特殊英语用法的语用研究:从句的解释
  • 批准号:
    20520443
  • 财政年份:
    2008
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of molecular mechanisms for common diseases caused by aging and oxidative stress and development of drug candidates aiming the molecular targets
衰老和氧化应激引起的常见疾病的分子机制研究以及针对分子靶点的候选药物开发
  • 批准号:
    15390029
  • 财政年份:
    2003
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel anti-atheroscleroic agents
新型抗动脉粥样硬化药物的开发
  • 批准号:
    12557220
  • 财政年份:
    2000
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on signal transduction mechanisms from nicotinic acetylcholine receptors to nucleus
烟碱型乙酰胆碱受体至细胞核信号转导机制的研究
  • 批准号:
    11680761
  • 财政年份:
    1999
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of Novel Function and Its Relation to Diseases for New Taget Proteins to Which Sulfonylureas Bind
磺酰脲类结合的新目标蛋白的新功能及其与疾病的关系的研究
  • 批准号:
    09470513
  • 财政年份:
    1997
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Drug binding in cardiac calcium channels : Identification and its application to drug development
心脏钙通道中的药物结合:鉴定及其在药物开发中的应用
  • 批准号:
    08044306
  • 财政年份:
    1996
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Development of the 4th generation calcium antagonists based on molecular revealing the binding sites in calcium channels
基于分子揭示钙通道结合位点开发第四代钙拮抗剂
  • 批准号:
    08557138
  • 财政年份:
    1996
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Chemical identification of the binding sites for calcium antagonists in cardiac calcium channels and its application to developing new drugs
心脏钙通道钙拮抗剂结合位点的化学鉴定及其在新药开发中的应用
  • 批准号:
    07457543
  • 财政年份:
    1995
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

抗glypican-3纳米抗体/抗菌肽融合蛋白对肝癌小鼠的靶向治疗
  • 批准号:
    31500752
  • 批准年份:
    2015
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
胞壁酰二肽-抗CD10复合物免疫导向治疗儿童急性B淋巴细胞性白血病微小残留病
  • 批准号:
    81400124
  • 批准年份:
    2014
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
中性粒细胞通过NETs释放LL37活化浆细胞样树突状细胞在ANCA相关性血管炎中的作用
  • 批准号:
    81400736
  • 批准年份:
    2014
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
抗Aβ中段自身抗体在阿尔茨海默病防治中的作用和机制研究
  • 批准号:
    81470058
  • 批准年份:
    2014
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目
p53四价功能域架构抗环瓜氨酸肽小分子抗体(CCP-TeAb)的构建及其拮抗类风湿关节炎自身免疫炎症作用的研究
  • 批准号:
    81360460
  • 批准年份:
    2013
  • 资助金额:
    50.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Bioelectric monitoring and neuromodulation of the heart
心脏的生物电监测和神经调节
  • 批准号:
    10655997
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
  • 批准号:
    10733789
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
Glycan biomarker panels in liquid biopsies for predicting treatment response in lupus nephritis
液体活检中的聚糖生物标志物组用于预测狼疮性肾炎的治疗反应
  • 批准号:
    10601270
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
Project 2: Mechanisms of Resistance to Neoantigen Vaccines in PDAC
项目2:PDAC新抗原疫苗耐药机制
  • 批准号:
    10708575
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
Development of Targeted Antipseudomonal Bactericidal Prodrugs
靶向抗假单胞菌杀菌前药的开发
  • 批准号:
    10678074
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了